Virbac - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Virbac Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Virbac. The Group's principal activities are the research, development, manufacture and distribution of veterinary drugs including antibiotics, anti-parasitic drugs, vaccines and dermatological drugs dedicated to animal health care. Their activities are carried out in the following sectors: Pets, Food Producing Animals and other related activities. The Group operates under the brand names Rilexin, Humigel, Novifit, Vet Aquadent, Tenotryl, Megaderm and Anxitan. The Group has operations accross the globe. In 2008, the Group acquired Pharmalett and Schering ranges.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report